NTRR Signs Letter of Intent with MMJ Technology Innovators

Before you go, we thought you'd like these...
Before you go close icon

NTRR Signs Letter of Intent with MMJ Technology Innovators

SARASOTA, Fla.--(BUSINESS WIRE)-- Neutra Corp. (OTCBB: NTRR), a fast-growing provider of all-natural wellness solutions, announced today that its medical marijuana (MMJ) subsidiary, Cannabis Technologies, Inc., has finalized a letter of intent to partner with Field of View Technologies, LLC, to deliver innovative new cannabis delivery systems.

NTRR is already negotiating a joint venture agreement with the Los Angeles-based company, which specializes in high-tech delivery systems. The partnership will be a major leap forward in Cannabis Technologies' aggressive expansion strategy for 2013.

"The growth potential of the emerging market for cannabinoid delivery systems is incredible," said NTRR CEO Sydney Jim. "Field of View Technologies has the right opportunities that we need to become a major player in this industry, and we're tremendously excited to move this relationship forward."

"We expect to announce a new definitive agreement with Field of View before the end of June," Mr. Jim added.

Smoke-free cannabinoid delivery systems have exploded in popularity with medical marijuana (MMJ) users in recent years. Vaporizers, throat sprays, transdermal patches and other innovations deliver the same therapeutic effects of the drug without the potential dangers and restrictions associated with more traditional pipes and cigarettes.

Through the California-based subsidiary Cannabis Technologies, Inc., NTRR is working to help introduce the next wave of healthier, more efficient delivery systems to the explosive $1.7 billion MMJ market. By providing innovative nutraceutical products and services such as new MMJ breakthroughs, Neutra Corp. plans to follow in the footsteps of other successful public companies including Cannabis Science, Inc. (OTCBB: CBIS), Medical Marijuana Inc. (OTCBB: MJNA) and Terra Tech Corp. (OTCBB: TRTC), delivering technological advancements in the cultivation and processing of cannabis in approved markets.

For more information on NTRR's initiatives, please visit www.neutracorp.com/investors.html.

About Neutra Corp.

Neutra Corp. (www.neutracorp.com) is a healthy lifestyle company that specializes in the development and marketing of natural wellness solutions, including cannabis-related products. For investing information and performance data, please visit www.neutracorp.com/investors.html.

Notice Regarding Forward-Looking Statements

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipate" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone's past success, either financial or strategic, is no guarantee of future success. This news release speaks as of the date first set forth above and the company assumes no responsibility to update the information included herein for events occurring after the date hereof.

Neutra Corp.
Sydney Jim, 813-367-2041
President and CEO

KEYWORDS:   United States  North America  California  Florida


The article NTRR Signs Letter of Intent with MMJ Technology Innovators originally appeared on Fool.com.

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Read Full Story

People are Reading